doxifluridine has been researched along with Cancer, Second Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emi, N; Ezaki, K; Handa, K; Hasegawa, A; Maruyama, F; Mizuta, S; Okamoto, M; Tsuzuki, M; Watanabe, M; Yamamoto, K; Yamamoto, Y | 1 |
| Etoh, T; Maeda, Y; Matoba, N; Nagata, T; Niiyama, H; Yoshida, J | 1 |
2 review(s) available for doxifluridine and Cancer, Second Primary
| Article | Year |
|---|---|
Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Floxuridine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neoplasms, Second Primary; Stomach Neoplasms; Time Factors | 2008 |
[Peritoneal dissemination of cecal cancer disappearing in a patient taking 5'-DFUR for 3 years].
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Cecal Neoplasms; Female; Floxuridine; Humans; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Peritoneal Neoplasms; Remission Induction | 1994 |